Anne Tybjærg‐hansen

Anne Tybjærg‐hansen's AcademicInfluence.com Rankings

Anne Tybjærg‐hansen

Philosophy

#7217

World Rank

#10398

Historical Rank

Logic

#4281

World Rank

#5552

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Anne Tybjærg‐hansen's Degrees

Doctorate Medicine University of Copenhagen
PhD Medical Sciences University of Copenhagen

Why Is Anne Tybjærg‐hansen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anne Tybjærg‐hansen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease (2013) (1786)
Lipoprotein(a) as a cardiovascular risk factor: current status (2010) (1466)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (2011) (1099)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease (2014) (883)
Remnant cholesterol as a causal risk factor for ischemic heart disease. (2013) (757)
Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. (2014) (673)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies (2012) (646)
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment (2015) (545)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease (2017) (537)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (2014) (470)
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. (2014) (442)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease (2016) (434)
Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. (2013) (409)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation (2013) (348)
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. (2013) (346)
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis (2018) (340)
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. (2016) (322)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study (2011) (295)
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2017) (294)
The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach (2012) (273)
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts (2013) (257)
New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
C-reactive protein levels and body mass index: Elucidating direction of causation through reciprocal Mendelian randomization (2010) (241)
Adiposity Amplifies the Genetic Risk of Fatty Liver Disease Conferred by Multiple Loci (2017) (238)
Angiotensinogen Gene Polymorphism, Plasma Angiotensinogen, and Risk of Hypertension and Ischemic Heart Disease: A Meta-Analysis (2003) (237)
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease A Meta-Analysis (1999) (224)
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms (2017) (224)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study (2008) (212)
Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. (2013) (202)
Short telomere length, cancer survival, and cancer risk in 47102 individuals. (2013) (198)
Does Greater Adiposity Increase Blood Pressure and Hypertension Risk?: Mendelian Randomization Using the FTO/MC4R Genotype (2009) (197)
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow‐up (2011) (193)
High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study. (2016) (183)
Short Telomere Length, Myocardial Infarction, Ischemic Heart Disease, and Early Death (2012) (182)
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. (2011) (177)
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. (2012) (175)
The Copenhagen City Heart Study (2003) (170)
Genetically Reduced Antioxidative Protection and Increased Ischemic Heart Disease Risk: The Copenhagen City Heart Study (2003) (165)
Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B: The Copenhagen City Heart Study (2007) (162)
A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency (2004) (158)
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. (2013) (151)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). (2018) (147)
Common Cholesteryl Ester Transfer Protein Mutations, Decreased HDL Cholesterol, and Possible Decreased Risk of Ischemic Heart Disease: The Copenhagen City Heart Study (2000) (144)
Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects. (2012) (143)
Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study. (2014) (142)
Hemochromatosis genotypes and risk of 31 disease endpoints: Meta‐analyses including 66,000 cases and 226,000 controls (2007) (141)
Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals (2018) (139)
Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis (2012) (135)
Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. (2011) (131)
U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies (2018) (124)
Plasma levels of apolipoprotein E and risk of dementia in the general population (2015) (124)
Genetic Variation in ABCA1 Predicts Ischemic Heart Disease in the General Population (2007) (121)
Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population (2007) (119)
Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976-2013. (2016) (118)
Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Blood Pressure as Mediators From Obesity to Ischemic Heart Disease (2015) (116)
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study (2015) (114)
Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study (2013) (112)
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population (2011) (111)
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis (2015) (106)
Genome-Wide Association Analysis of High-Density Lipoprotein Cholesterol in the Population-Based KORA Study Sheds New Light on Intergenic Regions (2008) (101)
Serum soluble CD163 predicts risk of type 2 diabetes in the general population. (2011) (101)
Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta‐analysis (2013) (94)
Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease (2015) (94)
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study (2017) (91)
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes (2018) (91)
Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease. (2010) (90)
Angiotensinogen Polymorphisms and Elevated Blood Pressure in the General Population: The Copenhagen City Heart Study (2001) (88)
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2021) (85)
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
Angiotensinogen Single Nucleotide Polymorphisms, Elevated Blood Pressure, and Risk of Cardiovascular Disease (2003) (84)
PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis. (2016) (80)
Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: Impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance (1997) (79)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
Advances in lipid-lowering therapy through gene-silencing technologies (2018) (78)
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study (2017) (77)
Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes (2006) (77)
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach (2010) (76)
C-Reactive Protein and Risk of Venous Thromboembolism in the General Population (2010) (75)
Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study (2011) (74)
TRIB1 and GCKR Polymorphisms, Lipid Levels, and Risk of Ischemic Heart Disease in the General Population (2011) (74)
Visible Age-Related Signs and Risk of Ischemic Heart Disease in the General Population: A Prospective Cohort Study (2014) (72)
Estrogen Receptor α Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture: Cross-Sectional, Cohort, and Case–Control Studies and a Meta-Analysis (2007) (70)
GUESS-ing Polygenic Associations with Multiple Phenotypes Using a GPU-Based Evolutionary Stochastic Search Algorithm (2013) (68)
Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy (2010) (68)
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life (2018) (68)
Integrin β3 Leu33Pro Homozygosity and Risk of Cancer (2003) (66)
Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. (2016) (65)
Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses. (2016) (64)
New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: Cross‐sectional and prospective studies and meta‐analyses of 75,000 cases and 93,000 controls (2011) (62)
Mutational analysis of the proopiomelanocortin gene in Caucasians with early onset obesity (1999) (60)
APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease (2001) (60)
Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy (2011) (60)
IDL, VLDL, chylomicrons and atherosclerosis (1992) (60)
Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease. (2015) (58)
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant (2020) (58)
Sterol transporter adenosine triphosphate–binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population (2011) (57)
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease (2004) (57)
Mitochondrial Haplogroups: Ischemic Cardiovascular Disease, Other Diseases, Mortality, and Longevity in the General Population (2008) (57)
Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study. (2011) (56)
Elevated Transferrin Saturation and Risk of Diabetes (2011) (56)
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137 895 Individuals (2018) (54)
Components of the Metabolic Syndrome and Risk of Type 2 Diabetes. (2016) (54)
Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population (2008) (53)
HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1 (2004) (53)
Platelet glycoprotein IIb/IIIa PlA2/PlA2homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: The Copenhagen City Heart Study (2003) (52)
Missense Variants in Plakophilin-2 in Arrhythmogenic Right Ventricular Cardiomyopathy Patients – Disease-Causing or Innocent Bystanders? (2009) (52)
Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study (2005) (52)
Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study (2018) (51)
25‐Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18 791 participants (2013) (50)
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis (2020) (50)
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals (2018) (50)
Endogenous sex hormones and risk of venous thromboembolism in women and men (2014) (50)
Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. (2013) (49)
Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride (2018) (49)
&bgr;2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies (2011) (48)
Organisation of the coding exons and mutational screening of the uncoupling protein 3 gene in subjects with juvenile-onset obesity (1998) (48)
Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis. (2014) (48)
Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk (2011) (48)
Extreme Concentrations of Endogenous Sex Hormones, Ischemic Heart Disease, and Death in Women (2015) (46)
Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation (2008) (45)
The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease. (2014) (45)
Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease. (2013) (45)
Measures to assess the prognostic ability of the stratified Cox proportional hazards model (2009) (44)
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population (2011) (43)
Blood Pressure, Risk of Ischemic Cerebrovascular and Ischemic Heart Disease, and Longevity in &agr;1-Antitrypsin Deficiency: The Copenhagen City Heart Study (2003) (43)
High body mass index and cancer risk—a Mendelian randomisation study (2016) (42)
Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. (2011) (42)
Identification of two novel missense mutations in the human OB gene (1997) (42)
Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals (2017) (41)
Genetic Stabilization of Transthyretin, Cerebrovascular Disease, and Life Expectancy (2013) (41)
Lipoprotein(a) and risk of myocardial infarction – genetic epidemiologic evidence of causality (2011) (40)
Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach (2012) (39)
The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts (2008) (39)
Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer (2009) (39)
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels (2011) (39)
Copy Number Variation in Glutathione S-Transferases M1 and T1 and Ischemic Vascular Disease: Four Studies and Meta-Analyses (2011) (38)
Alcohol Intake, Alcohol Dehydrogenase Genotypes, and Liver Damage and Disease in the Danish General Population (2009) (37)
Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention (2020) (36)
Hereditary hemochromatosis genotypes and risk of ischemic stroke (2007) (36)
Genetic Variation in ABCG1 and Risk of Myocardial Infarction and Ischemic Heart Disease (2012) (35)
Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis. (2020) (35)
Phenotype of Heterozygotes for Low-Density Lipoprotein Receptor Mutations Identified in Different Background Populations (2004) (34)
Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) (33)
ABC Transporter Genes and Risk of Type 2 Diabetes (2012) (33)
Genetically Reduced Soluble Epoxide Hydrolase Activity and Risk of Stroke and Other Cardiovascular Disease (2010) (32)
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text (2019) (32)
Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis (2019) (31)
Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study. (2019) (31)
Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population‐based study and meta‐analysis (2012) (30)
β2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals. (2012) (30)
Penetrance of NOD2/CARD15 genetic variants in the general population (2010) (29)
Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy (2010) (29)
YKL-40 levels and atrial fibrillation in the general population. (2013) (28)
Promotor Polymorphisms in Leukotriene C4 Synthase and Risk of Ischemic Cerebrovascular Disease (2008) (28)
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study (2005) (28)
Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. (2016) (27)
Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (26)
Blood–brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals (2019) (26)
Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. (2012) (26)
Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study (2020) (26)
164Ile allele in the &bgr;2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study (2005) (25)
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a). (2016) (25)
Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease (2018) (25)
Heterozygosity for R1141X in ABCC6 and Risk of Ischemic Vascular Disease (2011) (24)
APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) (24)
C-reactive Protein as a Predictor of Prognosis in COPD. (2006) (24)
Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study (2010) (23)
Use of Allele-Specific FAIRE to Determine Functional Regulatory Polymorphism Using Large-Scale Genotyping Arrays (2012) (22)
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals. (2021) (22)
Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality. (2019) (22)
Visible aging signs as risk markers for ischemic heart disease: Epidemiology, pathogenesis and clinical implications (2016) (21)
Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals (2018) (20)
Genetic Variants Associated With Increased Plasma Levels of Triglycerides, via Effects on the Lipoprotein Lipase Pathway, Increase Risk of Acute Pancreatitis. (2020) (20)
Gender- and age-specific contributions of additional DNA sequence variation in the 5′ regulatory region of the APOE gene to prediction of measures of lipid metabolism (2004) (19)
Prevention Familial hypercholesterolaemia in children and adolescents : gaining decades of life by optimizing detection and treatment (2015) (19)
Subsets of SNPs define rare genotype classes that predict ischemic heart disease (2006) (18)
Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population. (2021) (18)
NON-FASTING TRIGLYCERIDES AND RISK OF ISCHEMIC STROKE IN THE GENERAL POPULATION (2008) (18)
Mutation in Apolipoprotein B Associated with Hypobetalipoproteinemia Despite Decreased Binding to the Low Density Lipoprotein Receptor* (2005) (18)
Screening of three novel candidate genes in arrhythmogenic right ventricular cardiomyopathy. (2011) (18)
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia Published, JLR Papers in Press, November 29, 2005. (2006) (17)
β2‐adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals (2012) (17)
Cascade Screening in Families with Inherited Cardiac Diseases Driven by Cardiologists: Feasibility and Nationwide Outcome in Long QT Syndrome (2013) (17)
Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses. (2013) (17)
An application of the patient rule‐induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease (2007) (16)
32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT (2011) (15)
Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study (2014) (15)
Plasma HDL cholesterol and risk of dementia - observational and genetic studies. (2021) (14)
Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2 (2014) (14)
Context-Dependent Associations Between Variation in Risk of Ischemic Heart Disease and Variation in the 5′ Promoter Region of the Apolipoprotein E Gene in Danish Women (2010) (14)
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype (2005) (14)
Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals (2020) (14)
Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes (2013) (14)
Effect of APOE &egr; Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis (2017) (14)
C‐reactive protein levels and risk of dementia—Observational and genetic studies of 111,242 individuals from the general population (2022) (13)
Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease (2019) (13)
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review (2019) (13)
Abstract 16452: LCAT, HDL Cholesterol and Myocardial Infarction - A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals (2011) (13)
Novel genes in LDL metabolism – a comprehensive overview (2015) (12)
Common clinical practice versus new PRIM score in predicting coronary heart disease risk. (2010) (12)
Factor V Leiden: relation to fertility? (2002) (12)
Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts. (2016) (12)
C‐reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease (2009) (12)
Cystic Fibrosis ΔF508 Heterozygotes, Smoking, and Reproduction: Studies of 9141 Individuals from a General Population Sample (1998) (11)
Scavenger receptor AI/II truncation, lung function and COPD: a large population‐based study (2011) (11)
Response: Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies. (2013) (11)
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement (2019) (11)
ABCA7 and risk of dementia and vascular disease in the Danish population (2017) (11)
Using human genetics to predict the effects and side-effects of drugs (2016) (11)
The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease (2009) (11)
Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor–Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans (2018) (11)
Variation in 5' Promoter Region of the APOE gene Contributes to Predicting Ischemic Heart Disease (IHD) in the Population at Large: the Copenhagen City Heart Study (2007) (11)
A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor. (2019) (11)
Modifications to the Patient Rule‐Induction Method that utilize non‐additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease (2009) (10)
Medullary thyroid cancer: RET testing of an archival material (2010) (10)
Total and Cause-Specific Mortality by Elevated Transferrin Saturation and Hemochromatosis Genotype in Individuals With Diabetes: Two General Population Studies (2014) (10)
Lipoprotein(a) Levels at Birth and in Early Childhood - The COMPARE Study. (2021) (10)
Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population. (2020) (9)
Copy Number Variation in Glutathione S-Transferases M 1 and T 1 and Ischemic Vascular Disease Four Studies and Meta-Analyses (2011) (9)
Genetic Variation in Liver X Receptor Alpha and Risk of Ischemic Vascular Disease in the General Population (2011) (9)
Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer. (2015) (8)
Causal Associations in Type 2 Diabetes Development (2019) (8)
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement. (2019) (8)
Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease (2016) (8)
Genetic variation in WRN and ischemic stroke: General population studies and meta-analyses (2017) (8)
Elevated apolipoprotein A1 and HDL cholesterol associated with age-related macular degeneration: two population cohorts. (2021) (7)
Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality (2017) (7)
Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis (2021) (7)
Apolipoprotein M and risk of type 2 diabetes. (2020) (7)
Integrin &bgr;3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population (2007) (7)
Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose. (2020) (6)
A New Variant with Two Amino Acid Substitutions: Hb S‐Cameroon [β6(A3)Glu→Val;β90(F6)Glu→Lys] (2004) (6)
The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease. (2020) (6)
rs641738C>T near MBOAT7 promotes steatosis, NASH, fibrosis and hepatocellular carcinoma in non-alcoholic fatty liver disease: a meta-analysis (2020) (5)
The Sialylation Pathway and Coronary Artery Disease. (2016) (5)
Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population. (2015) (5)
Reply to letters regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation". (2014) (5)
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines. (2022) (5)
Plasma Concentrations of Magnesium and Risk of Dementia: A General Population Study of 102 648 Individuals. (2021) (5)
Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population (2015) (4)
Common and Rare Alleles in Apolipoprotein B Contribute to Plasma Levels of LDL Cholesterol in the General Population (2007) (4)
164Ile allele in the b2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study (2005) (4)
LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis (2018) (4)
Angiotensinogen mutations and risk of ischemic heart disease, myocardial infarction and ischemic cerebrovascular disease. Six case-control studies based on the Copenhagen City heart study (2001) (3)
Polygenic risk scores: how much do they add? (2021) (3)
Low LDL-cholesterol, PCSK9 and HMGCR genetic variation, and risk of neurodegenerative disease: A mendelian randomization study (2016) (3)
Hepatic lipase promoter SNPs associated with increased HDL cholesterol and paradoxically an increased risk of ischemic heart disease; the Copenhagen City Heart Study (2001) (3)
Genetic Variation in NPC1L1 and Risk of Gallstone Disease. (2015) (3)
DELTA F508 HETEROZYGOSITY AND ASTHMA. AUTHORS' REPLY (1998) (3)
rs641738C>T near MBOAT7 is positively associated with liver fat, ALT, and histological severity of NAFLD: a meta-analysis (2019) (3)
Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population Published, JLR Papers in Press, February 7, 2006. (2006) (3)
2.P.381 A common mutation (G−455 → A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study (1997) (3)
Impact of diet on ten-year absolute cardiovascular risk in a prospective cohort of 94 321 individuals: A tool for implementation of healthy diets (2022) (3)
Physical activity in leisure time and at work and risk of dementia: A prospective cohort study of 117,616 individuals. (2022) (2)
Abstract 17377: Plasma Levels of Apolipoprotein E and Risk of Dementia and Cerebrovascular Disease in the General Population (2013) (2)
Loss-of-function mutations in APOC3, remnant cholesterol, LDL cholesterol, and risk of ischemic vascular disease (2016) (2)
Lipoprotein(a) and familial hypercholesterolaemia - Authors' reply. (2016) (2)
Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population - cohort studies and meta-analyses of 362,338 individuals (2018) (2)
Genetic Variation in ABCG 1 and Risk of Myocardial Infarction and Ischemic Heart Disease (2011) (2)
Apolipoprotein E plasma level and genotype —/INS; Risk of dementia in 76,000 individuals from the general population (2013) (2)
Abstract 1690: Pre-Beta HDL and Lecithin:Cholesterol Acyltransferase Levels Are Strong Positive Diagnostic Risk Markers for Ischemic Heart Disease in Subjects with Both High and Low HDL-C Levels in the Copenhagen City Heart Study (2008) (2)
Increased Risk of Breast Cancer Associated With (2007) (2)
Abstract: S3-18 COMMON GENETIC VARIATION IN APOAI CONTRIBUTES TO ELEVATED HDL CHOLESTEROL IN THE GENERAL POPULATION (2009) (2)
Short and long QTc interval, cardiovascular disease and mortality (2013) (2)
Apolipoprotein E Genotype : epsilon 32 Women Are Protected While epsilon 43 and epsilon 44 Men Are Susceptible to Ischemic Heart Disease (2016) (2)
Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function (2022) (2)
Loss-of-function mutations in APOC3 and reduced risk of ischemic vascular disease (2014) (2)
1P-0098 Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: A meta-analysis (2003) (2)
Abstract 3706: Functional Mutation in ABCG1 Predicts Risk of Ischemic Heart Disease in the General Population (2008) (1)
Abstract 17184: A Genetic Variant Mimicking the Effect of Ezetimibe Associates With Increased Risk of Gallstone Disease (2013) (1)
Impact of LDL Cholesterol on Microvascular Versus MacrovascularDisease (2019) (1)
RESPONSE: Re: Integrin β3 Leu33Pro Homozygosity and Risk of Cancer (2004) (1)
Abstract 12959: Nonfasting Triglycerides and Cholesterol as Risk Predictors of Ischemic Stroke in the General Population. (2010) (1)
Macular Degeneration and CETP Inhibition-Reply. (2022) (1)
PROMOTOR POLYMORPHISMS IN CYSTEINYL LEUKOTRIENE SYNTHASE AND RISK OF ISCHEMIC CEREBROVASCULAR DISEASE (2008) (1)
Platelet Glycoprotein IIb / IIIa PlA 2 / PlA 2 Homozygosity Associated With Risk of Ischemic Cardiovascular Disease and Myocardial Infarction in Young Men The Copenhagen City Heart Study (2016) (1)
1.P.319 A common mutation T(−93)→G in the promoter of the lipoprotein lipase gene is associated with elevated plasma triglycerides in both genders and with ischemic heart disease in men. The Copenhagen City Heart Study (1997) (1)
Statin treatment, genetic inhibition of HMGCR and risk of symptomatic gallstone disease (2017) (1)
Abstract 17003: Increased Body Mass Index and Increased Risk of Ischemic Heart Disease: Using Genomewide Association Results to Estimate Causal Effects With Mendelian Randomization (2010) (1)
Adherence to established Danish dietary guidelines and risk of dementia - A prospective cohort study of 94,184 individuals (2021) (1)
ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma (2022) (1)
Abstract 12582: Genetically Reduced High-Density Lipoprotein Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study (2014) (1)
Investigating the combined association of BMI and alcohol consumption on liver disease and biomarkers: a Mendelian randomization study of over 90 000 adults from the Copenhagen General Population Study (2018) (1)
A rare genetic variant in the manganese transporter SLC30A10 and elevated liver enzymes in the general population (2022) (1)
Short t elomere l ength, c ancer Survival, and c ancer r isk in 47 102 i ndividuals (2013) (1)
Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis (2021) (1)
M.514 High throughput genotyping using the ABI prism 7900HT sequence detection system (2004) (1)
High LDL cholesterol levels and risk of peripheral vascular diseases - A mendelian randomization study including 106,548 individuals from the general population (2017) (1)
Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration. (2022) (1)
Triglycerides, Depression, and Risk of Ischemic Stroke—Reply (2009) (1)
Integrin 3 Leu 33 Pro Homozygosity and Risk of Cancer (2003) (1)
Pharmacogenetics-guided CETP inhibition: an open question? (2022) (1)
Abstract 16602: Genetic Variation in Liver X Receptor Alpha Predicts Risk of Ischemic Vascular Disease in 60,000 Individuals from the General Population (2010) (1)
3P-0845 Platelet glycoprotein IIb/IIIa P1A2/P1A2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men. The Copenhagen City Heart Study (2003) (1)
Components of the metabolic syndrome and risk of type 2 diabetes (2016) (1)
Abstract: P894 COPY NUMBER VARIATION IN GLUTATHIONE S-TRANSFERASES M1 AND T1 AND RISK OF ISCHEMIC CARDIOVASCULAR DISEASE (2009) (1)
A Regulatory Role of the Endosomal Sorting Machinery in Controlling Plasma LDL Cholesterol Levels and Atherosclerosis in Mice and Humans (2018) (1)
1417 THE MACROPHAGE-DERIVED SERUM BIOMARKER SOLUBLE CD163 INDEPENDENTLY PREDICTS LIVER CIRRHOSIS IN THE GENERAL POPULATION (2012) (1)
Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations. (2022) (1)
A Common Substitution ( Asn 291 Ser ) in Lipoprotein Lipase Is Associated with Increased Risk of Ischemic Heart Disease (2013) (1)
Genetically reduced high-density lipoprotein cholesterol and risk of type 2 diabetes: A mendelian randomization study (2014) (1)
A373P/R451Q CETP mutations, HDL cholesterol, and risk of ischemic heart disease. The Copenhagen city heart study (2000) (1)
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (1)
Abstract 15333: Aging Signs Predict Risk of Ischemic Vascular Disease Independent of Chronological Age (2012) (1)
Non-alcoholic fatty liver disease as a cause of ischemic heart disease: A mendelian randomization study and meta-analysis of 170,998 individuals (2016) (0)
Abstract 15369: Low Ldl-Cholesterol by Pcsk9 Variation and Mortality in 109,800 Individuals From the General Population (2017) (0)
Null Results in Brief Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer (2009) (0)
Abstract 14243: Genetic Variation in ABCG5/8 Associated with Lower Plasma LDL Cholesterol Protects Against Myocardial Infarction, but Increases the Risk of Gallstone Disease in the General Population (2012) (0)
Low LDL cholesterol by PCSK9 variation reduces cardiovascular and all-cause mortality - mendelian randomization of 109,566 individuals from Copenhagen (2018) (0)
Late-breaking abstract: Glutathione-S-transferase P1 Ile105Val polymorphism associated with elevated lung function and reduced risk of lung cancer and death in 66,000 individuals (2014) (0)
Front & Back Matter (2012) (0)
Plasma Tsh concentration and risk of cardiovascular disease: A Mendelian randomization study of 105,224 individuals from the general population. (2021) (0)
Cholesteryl Ester Transfer Protein Inhibitors and Access to the Retina in Age-Related Macular Degeneration-Reply. (2022) (0)
20 LCAT, HDL CHOLESTEROL AND MYOCARDIAL INFARCTION – A MENDELIAN RANDOMIZATION STUDY OF HDL CHOLESTEROL IN 54,500 INDIVIDUALS (2011) (0)
P4771Lipoprotein(a) levels at birth and in the neonatal period - the compare study (2018) (0)
41 GENETIC VARIATION IN TRANSTHYRETIN, LIPID AND LIPOPROTEIN LEVELS, AND RISK OF ISCHEMIC VASCULAR DISEASE (2011) (0)
GPR146 gene variants are associated with reduced plasma lipids and cardiovascular health: A novel role for GPR146 in hypolipidemia (2022) (0)
Glutathione S-transferases T1 and M1 and asthma risk in 10,000 individuals and in meta-analysis (2013) (0)
Factor V Leiden: relation to fertility? Authors' reply (2002) (0)
Plasma HDL cholesterol and risk of dementia – observational studies of 111,984 & genetic studies of 643,836 individuals (2021) (0)
Abstract 14067: Genetic Variation in APOA5 Associates with Stepwise Increases in Plasma Triglycerides and Risk of Myocardial Infarction in 58,000 Individuals from the General Population (2010) (0)
Abstract 3453: Genetically Elevated C-reactive Protein Does Not Cause Ischemic Heart Disease: Three Mendelian Randomization Studies (2007) (0)
Blood-Brain Barrier Transcytosis Genes, Risk Of Dementia And Stroke - A Prospective Cohort Study If 74,754 Individuals (2019) (0)
Reply to “Mendelian randomization highlights causal association between genetically increased C‐reactive protein levels and reduced Alzheimer's disease risk” (2022) (0)
Quantification of LPA KIV-2 repeats with next generation sequencing technology (2020) (0)
Using Human Genetics to Predict the Effects and Side Effects of Lipoprotein(a) Lowering Drugs. (2016) (0)
[The genome and cardiology]. (2014) (0)
Plasma transthyretin and risk of ischemic vascular disease in the general population: A prospective cohort study (2018) (0)
Coagulation Factor V ARG506GLN: Myocardial infarction and longevity (2000) (0)
The Addition of Niacin to Statin Therapy Improves High-Density Lipoprotein Cholesterol Levels But€Not Metrics of Functionality (2013) (0)
31 NONFASTING GLUCOSE AND ISCHEMIC HEART DISEASE – A MENDELIAN RANDOMIZATION APPROACH (2011) (0)
Splice site mutations in mismatch repair genes and risk of cancer in the general population (2013) (0)
Angiotensinogen gene mutations and hypertension in the general population. The Copenhagen City Heart Study (2000) (0)
Plasma Concentrations of Calcium and Risk of Alzheimer Disease-Observational and Genetic Studies. (2023) (0)
Abstract 1809: Prothrombin G20210A And Risk Of Venous Thromboembolism, Ischemic Heart Disease And Ischemic Cerebrovascular Disease In The General Population (2008) (0)
W14.391 Genetic variation in the ZINZ finger protein 202 gene in individuals from the general population with extreme HDL cholesterol levels (2004) (0)
Abstract 18433: Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Blood Pressure as Mediators from Obesity to Ischemic Heart Disease (2014) (0)
Abstract 3453: PCSK9 R46L Heterozygosity, Lifelong Low LDL Cholesterol Levels, and Disproportionately Lower Risk of Ischemic Heart Disease: Three Independent Studies and Meta-Analyses (2008) (0)
The use of gene probes to investigate the aetiology of arterial diseases (1990) (0)
Impact of vascular risk factors on 10-year absolute risk of dementia – risk charts for targeted prevention (2020) (0)
Abstract 1390: Composition Analysis of High Density Lipoproteins in Patients with extreme HDL-C Levels with or without Ischemic Heart Disease (2007) (0)
P80 XANTHELASMAS PREDICT RISK OF ISCHEMIC HEART DISEASE, MYOCARDIAL INFARCTION, AND OVERALL DEATH IN THE GENERAL POPULATION (2010) (0)
Rare GPR146 variants and their impact in the regulation of plasma lipid levels (2020) (0)
P103 HETEROZYGOSITY FOR R1141X IN ABCC6 AND RISK OF ISCHEMIC VASCULAR DISEASE (2010) (0)
A Common And A Rare Truncating Variant In Susd2 And Risk Of Ischemic Heart Disease (2019) (0)
04 - LOSS-OF-FUNCTION MUTATIONS IN ABCA1, HDL-CHOLESTEROL, METABOLOMIC PROFILES AND RISK OF VASCULAR DISEASE AND DEMENTIA – A COHORT STUDY OF UP TO 100,000 INDIVIDUALS (2019) (0)
Abstract 16954: SCARB1 Gene Variants are Associated With the New Lipid Phenotype of Combined High HDL-C and Lp(a) (2015) (0)
Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study (2014) (0)
Abstract: 119 MUTATION IN APOAI PREDICTS INCREASED RISK OF ISCHEMIC HEART DISEASE AND EARLY DEATH WITHOUT LOW HDL CHOLESTEROL (2009) (0)
Disminución de triglicéridos sin ayuno y reducción de mortalidad por cualquier causa: un estudio de randomización mendeliana Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study (2014) (0)
Abstract 17194: Genetically Elevated High-Density Lipoprotein Cholesterol and Unaffected Risk of Symptomatic Gallstone Disease: a Mendelian Randomization Study Challenging Reverse Cholesterol Transport (2013) (0)
Lawrence Berkeley National Laboratory Recent Work Title Relationship between genetic variation at PPP 1 R 3 B and levels of liver glycogen and triglyceride Permalink (2018) (0)
Abstract 14273: Extreme Lipoprotein(a) Levels, Corresponding LPA Risk Genotypes, and Improved Myocardial Infarction and Coronary Heart Disease Risk Prediction (2012) (0)
Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function And COPD In Smokers (2010) (0)
A comparison of cholesterol levels in umbilical cord blood and in neonatal blood - The compare study (2018) (0)
Blood Leukocyte Counts in Alzheimer Disease (2022) (0)
Abstract 14027: Xanthelasmata Predict Risk of Ischemic Heart Disease, Myocardial Infarction, and Overall Death in the General Population Independent of Cholesterol Levels (2010) (0)
Nonfasting Triglycerides and Cardiovascular Risk—Reply (2007) (0)
Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care (2009) (0)
W14.342 Variation in 5′ region contributes significantly to pleoiotropic effects of the APOE gene on multiple measures of lipid metabolism (2004) (0)
P-219: β2-adrenergic receptor gene and elevated blood pressure (2005) (0)
Abstract 4879: Resequencing APOAI Identifies Common Mutation that Predicts Increased Risk of Ischemic Heart Disease and Decreased Longevity without Dyslipidemia (2008) (0)
Polygenic risk scores: how much do they add? (2021) (0)
Abstract 15586: Null Mutations in APOC3 Are Not Uncommon in the General Population, Confer a Favorable Lipid Profile, and Apparent Cardioprotection (2011) (0)
589 GENETIC EVIDENCE THAT LIPOPROTEIN(A) CAUSES ATHEROSCLEROSIS RATHER THAN THROMBOSIS (2011) (0)
ApoE and vascular disease – resequencing and genotyping in a general population cohort (2021) (0)
GWAS : Genomewide association study HDLC : High-density lipoprotein cholesterol LD : Linkage disequilibrium LDL-C : Low-density lipoprotein cholesterol MAF : Minor allele frequency TC : Total cholesterol TG : Triglycerides Disclosures : none (2018) (0)
Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease. (2017) (0)
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes (2018) (0)
BASIC AND TRANSLATIONAL—BILIARY Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies (2016) (0)
P344 COMMON GENETIC VARIATION IN APOA1 CONTRIBUTES TO ELEVATED HDL CHOLESTEROL IN THE GENERAL POPULATION (2010) (0)
Effect of APOE e Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis (2017) (0)
Abstract 12568: Plasma Levels of Apolipoprotein E and Risk of Ischemic Heart Disease in the General Population (2014) (0)
1.P.280 A common substitution lle405Val in the cholesteryl ester transfer protein (CETP) is associated with increased HDL cholesterol and apolipoprotein Al. Studies in a general population sample of 8,989 women and men (1997) (0)
Low LDL-cholesterol , PCSK 9 and HMGCR genetic variation , and risk of Alzheimer ’ s dementia and Parkinson ’ s disease : a Mendelian randomization study (2017) (0)
W38 GENETIC VARIATION IN LIVER X RECEPTOR ALPHA AND RISK OF ISCHEMIC VASCULAR DISEASE IN THE GENERAL POPULATION (2010) (0)
Plasma Transthyretin And Risk Of Incident Heart Failure (2019) (0)
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2018) (0)
Triglycerides, Depression, and Risk of Ischemic Stroke. Authors' reply (2009) (0)
Abstract 19298: Heterozygosity for ABCC6 R1141X Does Not Associate with Risk of Ischemic Vascular Disease in 67,000 Individuals Including 14,000 Ischemic Events (2010) (0)
2P-0449 Complete genetic variation in the ABCA1 gene in individuals with extreme HDL levels (2003) (0)
Abstract 15466: Genetically Elevated Bilirubin and Risk of Ischemic Heart Disease: a Mendelian Randomization Study of the General Population (2011) (0)
Scavenger receptor AI/II truncation, lung function and COPD in 48,700 individuals: Abstracts - other lecturers (2011) (0)
Cardiovascular Disease and Cardiovascular Risk Factors Subgroups at high risk for ischaemic heart disease: identification and validation in 67000 individuals from the general population (2015) (0)
Abstract 5093: Genetically Elevated Lipoprotein(a) and Risk of Myocardial Infarction - a Positive Mendelian Randomization Study (2008) (0)
D014: Angiotensinogen gene mutations and hypertension in the general population (2000) (0)
Genetic and Functional Characterization of ANGPTL7 as a Therapeutic Target for Glaucoma (2021) (0)
P342 COMMON GENETIC VARIATION IN APOA5, LEVELS OF TRIGLYCERIDES AND RISK OF MYOCARDIAL INFARCTION IN THE GENERAL POPULATION (2010) (0)
Body mass index and mortality over 3 decades (2016) (0)
Correction: Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer (2010) (0)
High Glucose Levels And Risk Of Vascular Diseases – Observational And Mendelian Randomization Studies Of The General Population (2019) (0)
Plasma Transthyretin And Risk Of All-Cause And Cardiovascular Mortality In The General Population: Two Prospective Cohort Studies (2019) (0)
Common Genetic Variation in MC4R Does Not Affect Atherosclerotic Plaque Phenotypes and Cardiovascular Disease Outcomes (2021) (0)
The coatomer (COP I) complex limits the cell-surface abundance of the ldl receptor and cellular LDL uptake (2020) (0)
Abstract 11995: Extreme Endogenous Testosterone and Estrogen Concentrations and Risk of Ischemic Stroke in Men and Women: A Prospective Cohort Study and Meta-Analyses (2014) (0)
Splice site mutations in mismatch repair genes and risk of cancer in the general population (2013) (0)
Plasma Tsh Concentration And Risk Of Cardiovascular Disease In The General Population (2019) (0)
Abstract 15977: A Stabilizing Variant in Transthyretin, T119M, and Risk of Ischemic Vascular Disease (2012) (0)
17 THE PLASMA CONCENTRATION OF HDL-ASSOCIATED APOM IS CONTROLLED BY THE ACTIVITY OF THE LDL-RECEPTOR (2011) (0)
The U2-spliceosome and its interactors regulate the levels and activity of the LDL receptor in humans (2020) (0)
Short t elomere length, cancer Sur vival, and cancer r isk in 47 1 02 individuals (2013) (0)
GENETICALLY ELLEVATED C-REACTIVE PROTEIN AND ISCHEMIC HEART DISEASE: THREE MENDELIAN RANDOMIZATION STUDIES (2008) (0)
Abstract 14092: Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease (2012) (0)
SCREENING FOR THE APO B(ARG3500-]GLN) MUTATION (1989) (0)
Abstract 15100: Nonfasting Glucose and Ischemic Heart Disease a Mendelian Randomization Approach (2011) (0)
Abstract 20818: Liver Fat Content, NAFLD, and Ischemic Heart Disease: Mendelian Randomization and Meta-Analysis of 279,013 Individuals (2017) (0)
The 447 truncation of lipoprotein lipase, lipids and lipoproteins, and risk of ischemic heart disease. The Copenhagen City Heart Study and updated meta-analysis (2000) (0)
Genetic Variation In Ppp1r3b And Plasma Levels Of Glucose, Lipids, And Liver Enzymes In The Danish General Population (2019) (0)
O-4: Cloning and mutational analysis of the ob gene in juvenile onset obesity (2009) (0)
Abstract 1092: Genetically Low HDL Cholesterol without Increased Risk of Ischemic Heart Disease (2007) (0)
1.P.273 Hypercholesterolemia and the risk of ischemic heart disease in individuals with mutations causing familial defective apolipoprotein B100. The Copenhagen City heart study (1997) (0)
Mo-P6:450 Beta2-adrenergic receptor gene polymorphisms do not predict cardiovascular disease in the general (2006) (0)
491 FACIAL WRINKLES, GREY HAIR AND BALDNESS PREDICT RISK OF ISCHEMIC HEART DISEASE AND ISCHEMIC CEREBROVASCULAR DISEASE INDEPENDENT OF CHRONOLOGICAL AGE (2011) (0)
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals (2022) (0)
A mutation in the beta-fibrinogen promoter raises plasma fibrinogen, an independent risk factor for ischemic heart disease in men and women in the Copenhagen City Heart Study (1996) (0)
Genetic inhibition of CETP and risk of dementia, age-related macular degeneration and cardiovascular mortality (2020) (0)
Abstract: 1081 FUNCTIONAL MUTATION IN ABCG1 PREDICTS RISK OF ISCHEMIC HEART DISEASE IN THE GENERAL POPULATION (2009) (0)
Abstract 18766: Low-Density-Lipoprotein-Cholesterol and Risk of Diabetes: A Mendelian Randomization Study (2016) (0)
Importance of non-synonymous genetic variation in wrn on risk of ischemic vascular disease and mortality in the general population (2014) (0)
Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al. (2016) (0)
Genetic variation in ABCA1 and risk of all-cause dementia, age-related macular degeneration, and ischemic heart disease (2021) (0)
257-OR: High Glucose Levels and Risk of Vascular Diseases—Observational Studies and Mendelian Randomization Studies of the General Population (2019) (0)
Elevated apolipoprotein A1 and HDL cholesterol associated with age-related macular degeneration: Two population cohorts (2021) (0)
Beta2-Adrenergic Receptor Polymorphism Associated With Reduced Lung Function In Two Large Populations (2011) (0)
Factor V Leiden and Venous Thromboembolism (2004) (0)
The need to focus on primary health care for chronic diseases (2016) (0)
Corrigendum (2014) (0)
Mild hypercholesterolemia and premature heart disease: Reply (2001) (0)
Nicotinic acetylcholine receptor polymorphism, smoking history, and tobacco-related cancer in the general population. (2010) (0)
551 EFFECT OF BODY MASS INDEX ON ISCHAEMIC HEART DISEASE RISK: OBSERVATIONAL AND CAUSAL ESTIMATES ON 76000 INDIVIDUALS (2011) (0)
Response to letter regarding article, "visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study". (2014) (0)
University of Groningen A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor Biobank Based Int (2019) (0)
CETP mutations identified in Caucasians with high or low HDL cholesterol (2000) (0)
Loss-Of-Function Mutations In Abca1, Hdl-Cholesterol, Metabolomic Profiles And Risk Of Vascular Disease And Dementia – A Cohort Study Of Up To 100,000 Individuals (2019) (0)
Physical inactivity and risk of dementia and cardiovascular disease -A prospective study of 117,616 individuals (2021) (0)
Observational and genetic studies of C‐reactive protein levels and risk of Alzheimer's disease (2022) (0)
Functional mutation in ABCA1, plasma levels of apolipoprotein E and risk of alzheimer disease and cerebrovascular disease (2015) (0)

This paper list is powered by the following services:

Anne Tybjærg‐hansen's Academic­Influence.com Rankings

Anne Tybjærg‐hansen's Degrees

Why Is Anne Tybjærg‐hansen Influential?

Anne Tybjærg‐hansen's Published Works

Published Works

Anne Tybjærg‐hansen's AcademicInfluence.com Rankings